---
title: "After the plunge, Middle Eastern funds and top-tier funds enter the market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238525314.md"
description: "On April 29th, Xingqi Pharmaceutical's stock price surged by 14.14%. According to the company's quarterly report, the Kuwait Investment Authority and the Central European Fund Manager, Glen, have newly entered the top ten circulating shareholders of Xingqi Pharmaceutical. Since June of last year, Xingqi Pharmaceutical's stock price has undergone significant adjustments. By the end of the first quarter of 2025, the Kuwait Investment Authority held 2.9353 million shares, and the Central European Healthcare Mixed Fund managed by Glen held 939,000 shares"
datetime: "2025-05-02T04:04:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238525314.md)
  - [en](https://longbridge.com/en/news/238525314.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238525314.md)
generator: "portal-rs"
---

# After the plunge, Middle Eastern funds and top-tier funds enter the market

On April 29th, Xingqi Pharmaceutical surged 14.14%. The company's quarterly report shows that in the first quarter of this year, the Kuwait Investment Authority and the well-known fund manager of China Europe Fund, Ge Lan, significantly increased their positions, both newly entering the top ten circulating shareholders of Xingqi Pharmaceutical. From the stock price trend of Xingqi Pharmaceutical, since June of last year, the stock price has experienced severe adjustments. According to Xingqi Pharmaceutical's Q1 2025 report, as of the end of the first quarter of this year, the Kuwait Investment Authority became a new entrant among the top ten circulating shareholders of Xingqi Pharmaceutical, holding 2.9353 million shares; the China Europe Medical Health Mixed Fund managed by Ge Lan held 939,000 shares, also newly entering the top ten circulating shareholders

### Related Stocks

- [300573.CN](https://longbridge.com/en/quote/300573.CN.md)

## Related News & Research

- [Scandinavian Investment Group reports CEO Michael Hove SIG share transaction](https://longbridge.com/en/news/297538758.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [Pusula Finans to Boost Stake in Katılımevim with TRY 10 Billion Share Buy Plan](https://longbridge.com/en/news/297423163.md)
- [Chenming Paper says all five major production bases fully resume operations after Zhanjiang restart](https://longbridge.com/en/news/297329752.md)
- [14:15 ETCariloha Launches New Sheet Styles, Bringing Vacation Comfort and Superior Sleep to Home Bedding](https://longbridge.com/en/news/297550384.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**